Climate change is a public health emergency. Healthcare organizations have a moral imperative to work together and create a healthier environment for their communities.
Merck executives share their strategy for embedding health equity across the pharma value chain.
Plus, Why We Should Still Be Thinking About Cumulative Population Immunity
Three takeaways from our analysis on possible Herd Immunity Threshold and how to reach it together.
Q&A with Esther Dyson
Non-profit Wellville helps communities build sustainable institutions and systems for the health and resilience of all their residents.
The distribution of COVID-19 vaccines like Moderna, Pfizer, and others demands immediate supply chain analysis and preparation.
New Oliver Wyman analysis on when and how a vaccine may be available and key considerations for how to reach herd immunity.
An Executive Q&A About an Industry With and Without Barriers
With consumer interest in virtual care booming, someone's home is often a sacred space that reveals contextual health details.
Six strategies to optimize care while protecting those on the front lines of battling COVID-19.
Some of the best COVID-19 solutions to support Special Populations require unconventional methods.
Strategies and tactics to help hospitals and health systems prepare their operations and clinical teams for a fast-evolving emergency situation.